Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huoxuetongluofang external washing for chemotherapy-induced peripheral neuropathy
ChiCTR-TRC-13003605Phase 3Completed
- Sponsor
- Guang'anmen Hospital
- Start
- Jan 2013
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of Huoxuetongluofang and huang qi gui zhi wu wu tang in chemotherapy-induced peripheral neuropathy (CIPN) (3 arms), sponsored by Guang'anmen Hospital. Primary endpoint: Grading of peripheral nerve injury. Started Jan 2013; status: completed.
02
Drugs
Huoxuetongluofanghuang qi gui zhi wu wu tang
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on ChiCTR-TRC-13003605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003605.